You just read:

ISTA Pharmaceuticals Initiates Phase 2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis

News provided by

ISTA Pharmaceuticals, Inc.

Dec 14, 2010, 07:30 EST